Answer
In long-term clinical trials of intrathecal ziconotide acetate, dizziness was reported in 42% of patients and nausea in 30%.
Sources for this answer
- Prialt 100 micrograms/ml solution for infusionEsteve Pharmaceuticals (formerly Intrapharm Laboratories) · emc · SmPC §4.8 Undesirable effects · Version 15Document updated
Sources checked